Physician Sentenced to 18 Years in Prison for Operating a Pill Mill from His Northwest D.C. Medical Practice
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Physician Sentenced to 18 Years in Prison for Operating a Pill Mill from His Northwest D.C. Medical Practice

Physician Sentenced to 18 Years in Prison for Operating a Pill Mill from His Northwest D.C. Medical Practice

June 26, 2025
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Public Information Office
Phone Number: (571) 362-1934

Investigation also resulted in the revocation of Okafor’s DEA registration number

WASHINGTON -- Ndubuisi Joseph Okafor, M.D., 65, of Upper Marlboro, Maryland, was sentenced today in U.S. District Court to 18 years in prison for illegally distributing prescriptions for narcotics in exchange for cash from his Northwest Washington D.C. medical clinic. 

A jury found Okafor guilty on Mar. 21, 2025, of conspiracy to distribute controlled substances (outside the course of professional practice), maintaining a drug-involved premises, and 22 counts of unlawful distribution of controlled substances (oxycodone and promethazine with codeine).

In addition to the 18-year prison term, U.S. District Judge John D. Bates ordered Okafor to serve three years of supervised release to pay a special assessment, and to forfeit $213,173.97.

According to court documents and evidence at trial, between May 2021 and April of 2023, Okafor was the sole practitioner and owner of Okafor Medical Associates, an internal medicine clinic in Northwest, Washington, D.C. The U.S. Attorney’s Office, the HHS-OIG, and FBI began investigating Okafor for illegal distribution of controlled substances after it received information from law enforcement agencies nationwide regarding prescriptions from Okafor being connected to local drug trafficking networks.

The investigation also resulted in the revocation of Okafor’s DEA registration number in September 2023 as he was deemed to be a threat to public health and safety.

Between Feb. 18, 2022, and Nov. 30, 2022, the FBI sent confidential sources and undercover agents into Okafor’s medical practice for walk-in appointments. Each individual was prescribed opioids by Okafor after minimal examination. Further investigation revealed that Okafor was operating a nationwide drug distribution scheme, whereby he would prescribe opioids to numerous individuals using false identities, whom Okafor knew to be diverting the medication.

Okafor’s conduct spanned at least 45 states and resulted in hundreds of thousands of units of oxycodone and promethazine with codeine liquid prescribed nationwide. Okafor was convicted of distribution of opioids to undercover sources, numerous uncharged co-conspirators, and to a civilian patient J.V. Okafor was also convicted of conspiracy and maintaining a drug-involved premises. Evidence at trial further established that, after Okafor was notified by the D.C. Board of Health that J.V.’s family member filed a complaint against him, he created backdated medical records for J.V. to justify his prescribing.

The case was investigated by the FBI’s Washington Field Office and the U.S. Department of Health and Human Services, Office of Inspector General, Office of Investigations and the District of Columbia Office of the Inspector General’s Medicaid Fraud Control Unit, with valuable assistance from the Drug Enforcement Administration’s Washington Division.

The U.S. Attorney’s Office and Justice Department gratefully acknowledge the Apex, North Carolina Police Department, the Warsaw, New York, Police Department, the North Dakota Bureau of Criminal Investigations, Pennsylvania State Police, State of Ohio Board of Pharmacy, and the Noble County, Ohio, Sheriff’s Office for their efforts, support, and cooperation during the investigation and trial.

The case was prosecuted by Assistant United States Attorney Meredith Mayer-Dempsey, Trial Attorney Kathryn Furtado and paralegals Rebecca Walton, Dillon Clark, and Matthew McClarnon of the Justice Department’s Fraud Section. The team also extends its deep appreciation to Michael Goodrich, Lead Travel Analyst of the Justice Department’s Fraud Section. 

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Christopher C. Goumenis Special Agent in Charge - Washington, DC
@DEAWashingtonDC
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster